Immunological markers for identifying recent HIV infection in North-West India

被引:8
作者
Chauhan, Chandar Kanta [1 ]
Lakshmi, P. V. M. [1 ]
Sagar, Vivek [1 ]
Sharma, Aman [2 ]
Arora, Sunil K. [3 ]
Kumar, Rajesh [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Sch Publ Hlth, Dept Community Med, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India
[3] Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh, India
关键词
CAPTURE ENZYME-IMMUNOASSAY; AVIDITY; MOBILITY; TYPE-1; SURVEILLANCE; THERAPY; TIME; SEX;
D O I
10.4103/ijmr.IJMR_2007_18
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: Being more efficient and widely used, limiting antigen (LAg)-avidity enzyme immunoassay (EIA) based on the recent infection testing algorithm (RITA) has been developed for differentiating recent and established HIV-1 infection. So far, LAg-avidity EIA has not been validated among the Indian population. Hence, the present study was planned to identify recent HIV infections in high risk patients in the North-West region of India using modified LAg-avidity RITA. Methods: Four hundred HIV-positive high risk patients registered on pre-antiretroviral therapy (ART) programme in the last one year, from five ART centres in North-Western States of India, were included for identifying the recent HIV infections. One hundred HIV-positive cases registered for pre-ART for greater than two years in ART centres were included for estimating false recent rate (FRR). Single-well LAg-avidity EIA-based modified RITA was used to identify recent HIV infection cases. Results: Of the 400 HIV-1-positive samples, 64 (16%) were found to have been infected within the past 130 days. The proportion of recent HIV infections was 16.8 per cent (18/107) among female sex workers, 10.7 per cent (9/84) among men who have sex with men and 17.7 per cent (37/209) among injecting drug users. The FRR was one per cent (1/100). Interpretation & conclusions: LAg-avidity EIA-based modified RITA provided good discrimination between recent and non-recent HIV infection, hence, it could be considered suitable for estimating HIV incidence in sentinel surveillance system in India.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 23 条
[1]  
[Anonymous], 2017, END AIDS PROGR 90 90
[2]   Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes [J].
Chawla, A. ;
Murphy, G. ;
Donnelly, C. ;
Booth, C. L. ;
Johnson, M. ;
Parry, J. V. ;
PhillipS, A. ;
Geretti, A. M. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (02) :415-420
[3]   Linking migration, mobility and HIV [J].
Deane, Kevin D. ;
Parkhurst, Justin O. ;
Johnston, Deborah .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (12) :1458-1463
[4]  
Joint United Nations Programme on HIV/AIDS, 2020, GLOB HIV AIDS STAT 2
[5]   Investigating the utility of the HIV-1BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa [J].
Karita, Etienne ;
Price, Matt ;
Hunter, Eric ;
Chombad, Elwyn ;
Allen, Susan ;
Fei, Lin ;
Kamali, Anatoli ;
Sanders, Eduard J. ;
Anzala, Omu ;
Katende, Michael ;
Ketter, Nzeera .
AIDS, 2007, 21 (04) :403-408
[6]   Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results [J].
Karon, John M. ;
Song, Ruiguang ;
Brookmeyer, Ron ;
Kaplan, Edward H. ;
Hall, H. Irene .
STATISTICS IN MEDICINE, 2008, 27 (23) :4617-4633
[7]   Estimating HIV Incidence among Adults in Kenya and Uganda: A Systematic Comparison of Multiple Methods [J].
Kim, Andrea A. ;
Hallett, Timothy ;
Stover, John ;
Gouws, Eleanor ;
Musinguzi, Joshua ;
Mureithi, Patrick K. ;
Bunnell, Rebecca ;
Hargrove, John ;
Mermin, Jonathan ;
Kaiser, Reinhard K. ;
Barsigo, Anne ;
Ghys, Peter D. .
PLOS ONE, 2011, 6 (03)
[8]   Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence [J].
Kothe, D ;
Byers, RH ;
Caudill, SP ;
Satten, GA ;
Janssen, RS ;
Hannon, WH ;
Mei, JV .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (05) :625-634
[9]   Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need Following Changes in Treatment Guidelines [J].
Lodi, Sara ;
Phillips, Andrew ;
Touloumi, Giota ;
Geskus, Ronald ;
Meyer, Laurence ;
Thiebaut, Rodolphe ;
Pantazis, Nikos ;
del Amo, Julia ;
Johnson, Anne M. ;
Babiker, Abdel ;
Porter, Kholoud .
CLINICAL INFECTIOUS DISEASES, 2011, 53 (08) :817-825
[10]  
Moyo S, 2017, AIDS RES HUM RETROV, V33, P17, DOI [10.1089/aid.2016.0127, 10.1089/AID.2016.0127]